Judd Hartman, General Counsel at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 20,000 shares at $42.55 ($846K) on 2008-05-02, disclosed to the SEC on 2008-05-06.
Open-market sale of $846k PPDI by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.51 | 6,195 | $257K | 30.4% |
| 2 | $42.50 | 400 | $17K | 2.0% |
| 3 | $42.52 | 1,299 | $55K | 6.5% |
| 4 | $42.53 | 1,800 | $77K | 9.1% |
| 5 | $42.54 | 600 | $26K | 3.0% |
| 6 | $42.55 | 100 |
| $4K |
| 0.5% |
| 7 | $42.59 | 100 | $4K | 0.5% |
| 8 | $42.63 | 400 | $17K | 2.0% |
| 9 | $42.64 | 1,200 | $51K | 6.0% |
| 10 | $42.65 | 1,232 | $53K | 6.2% |
| 11 | $42.66 | 200 | $9K | 1.0% |
| 12 | $42.67 | 900 | $38K | 4.5% |
| 13 | $42.68 | 900 | $38K | 4.5% |
| 14 | $42.69 | 300 | $13K | 1.5% |
| 15 | $42.70 | 1,100 | $47K | 5.6% |
| 16 | $42.71 | 1,588 | $68K | 8.0% |
| 17 | $42.79 | 402 | $17K | 2.0% |
| 18 | $42.81 | 500 | $21K | 2.5% |
| 19 | $42.82 | 384 | $16K | 1.9% |
| 20 | $42.84 | 2 | $86 | 0.0% |
| 21 | $42.85 | 300 | $13K | 1.5% |
| 22 | $42.86 | 98 | $4K | 0.5% |
| Total | $42.29 avg | 20,000 | $846K | 100% |
| Filing → |
| PPDI | SELL | 2007-05-21 | $1.4M | — | Filing → |